The skin microbiome enhances disease through IL-1b and delays healing in cutaneous leishmaniasis patients.
The skin microbiome enhances disease through IL-1b and delays healing in cutaneous leishmaniasis patients.
复制标题
皮肤微生物群通过 IL-1b 增强疾病并延迟皮肤利什曼病患者的愈合。
DOI:
10.1101/2023.02.02.23285247
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Grice,ElizabethA
中科院分区:
文献类型:
--
作者:
FariasAmorim,Camila;Lovins,VictoriaM;Singh,TejPratap;Novais,FernandaO;Harris,JordanC;Lago,AlexsandroS;Carvalho,LucasP;Carvalho,EdgarM;Beiting,DanielP;Scott,Phillip;Grice,ElizabethA
Leishmania braziliensisis a parasitic infection that can result in inflammation and skin injury with highly variable and unpredictable clinical outcomes. Here, we investigated the potential impact of microbiota on infection-induced inflammatory responses and disease resolution by conducting an integrated analysis of the skin microbiome and host transcriptome on a cohort of 62 patients infected withL. braziliensis. We found that overall bacterial burden and microbiome configurations dominated withStaphylococcusspp. were associated with delayed healing and enhanced inflammatory responses, especially by IL-1 family members. Quantification of host and bacterial transcripts on human lesions revealed that high lesionalS. aureustranscript abundance was associated with delayed healing and increased expression of IL-1β. This cytokine was critical for modulating disease outcomes inL. braziliensis–infected mice colonized withS. aureus, given that its neutralization reduced pathology and inflammation. These results highlight how the human microbiome can shape disease outcomes in cutaneous leishmaniasis and suggest pathways toward host-directed therapies to mitigate the inflammatory consequences.